Clinical Trials
45 trialsSBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
Fudan University
POSTILV
Radiation Therapy Oncology Group
Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)
Fudan University
Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
Sun Yat-sen University
BRPCNCC-1
Changhai Hospital
SBRT Plus vNKT for Pancreatic Cancer
Changhai Hospital
TaRRGET
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs
Shanghai Cancer Hospital, China
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
California Pacific Medical Center Research Institute
Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence
Huashan Hospital
Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC
Huazhong University of Science and Technology
IMCORT-2
Sichuan Cancer Hospital and Research Institute
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Fudan University
HiSparCK
Ottawa Hospital Research Institute
MASTERPLAN
Australasian Gastro-Intestinal Trials Group
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
The University of Hong Kong
CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
Accuray Incorporated
SHINE
McMaster University
PBS
Juravinski Cancer Center
Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC
West China Hospital
Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Zhejiang Cancer Hospital
LungTech
European Organisation for Research and Treatment of Cancer - EORTC
Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT
Sun Yat-sen University
SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC
Fudan University
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
Korea Cancer Center Hospital
Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis
ChineseAMS
CLEAR
Gangnam Severance Hospital
Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer
National Cancer Centre, Singapore
Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer
West China Hospital
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Hangzhou Cancer Hospital
CyberKnife Radiosurgery for Locally Recurrent Prostate CA
CyberKnife Centers of San Diego
CyberKnife Radiosurgery for Localized Prostatic Carcinoma
CyberKnife Centers of San Diego
Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation
Sichuan Cancer Hospital and Research Institute
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife
Tianjin Medical University Cancer Institute and Hospital
Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer
ChineseAMS
Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC
ChineseAMS
Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT
Juravinski Cancer Center
SPARC
Royal Marsden NHS Foundation Trust
Definitive Therapy for Oligometastatic Solid Malignancies
Rocky Mountain Cancer Centers
Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
AHS Cancer Control Alberta
The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases
Tel-Aviv Sourasky Medical Center
Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis
Tel-Aviv Sourasky Medical Center
Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
Office of Rare Diseases (ORD)